Connect with us

Hi, what are you looking for?

Digital Platforms

Anthony Fernando: CEO of Asensus Surgical

Joe Mullings, Chairman of the Board for TMG360, and Anthony Fernando, CEO of Asensus Surgical sat down to speak about the rebranding of TransEnterix to Asensus Surgical and the emerging initiatives and areas of pursuit for the platform.

Anthony Fernando: CEO of Asensus Surgical

Joe Mullings, Chairman of the Board for TMG360, and Anthony Fernando, CEO of Asensus Surgical sat down to speak about the rebranding of TransEnterix to Asensus Surgical and the emerging initiatives and areas of pursuit for the platform.

The Asensus Surgical team is hyper-focused on enhancing surgical performance and looking beyond the industry’s potential over-indexing towards a “robot”.

Learn more about the Asensus mission, market dynamics, and some of the large strategics challenges with bringing an abdominal surgical robotic platform to market in the full interview above.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Diagnostics

PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.

HealthTech

Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies

BioTechnology

The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   

Exclusives

Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like

Exclusives

Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...

Exclusives

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Exclusives

Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...

Exclusives

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.